Rockefeller Capital Management
ENTA icon

Rockefeller Capital Management’s Enanta Pharmaceuticals ENTA Stock Holding History

Rockefeller Capital Management’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.19M Buy
150,546
+147,983
+5,774% +$1.99M ﹤0.01% 1336
2026
Q1 		$32.4K Buy
2,563
+2,049
+399% +$27.5K ﹤0.01% 3483
2025
Q4 		$8.11K Buy
+514
New +$6.53K ﹤0.01% 3898
2019
Q2 		– Sell
-21
Closed -$2K – 1744
2019
Q1 		$2K Buy
+21
New +$1.88K ﹤0.01% 1781

Other funds holding ENTA

JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KAM
Krensavage Asset Management New York $263M AUM 66.99% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SSC
Spruce Street Capital New York $510M AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Rockefeller Capital Management's ENTA Position: Q2 2026 in Review

Rockefeller Capital Management increased its Enanta Pharmaceuticals (ENTA) stake by 5,774% in Q2 2026, buying an estimated $1.99M and bringing the position to 150,546 shares worth $2.19M. The position accounts for ﹤0.01% of the portfolio, ranked #1336.

Rockefeller Capital Management first reported a position in ENTA in Q1 2019 and has held it in 4 quarters since. 123 funds tracked by Wall St. Rank hold ENTA as of Q2 2026.

  • Rockefeller Capital Management held 150,546 shares of Enanta Pharmaceuticals worth $2.19M as of Q2 2026.
  • Rockefeller Capital Management bought 147,983 Enanta Pharmaceuticals shares in Q2 2026, an estimated $1.99M.
  • Enanta Pharmaceuticals made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #1336 holding.
  • Rockefeller Capital Management first reported a position in Enanta Pharmaceuticals in Q1 2019 and has held it in 4 quarters since.
  • 123 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.